Maya Goldman

Former Louisiana Surgeon General Ralph Abraham also backed the unproven COVID treatment ivermectin.

Medicare negotiated a list price of $274 for a month's supply of Ozempic and its related medications.

It marks the Trump administration's first shot at putting its mark on the privatized Medicare program.

Changes to how Medicare pays hospitals to give outpatient drugs would save $11 billion in a decade.

It's another case of the administration putting public health on a collision course with immigration policy.

The public health agency is publicly reversing its position on a link between vaccines and the condition.

The termination of federal research grants disrupted about 1 in 30 NIH-funded clinical trials.

The shutdown's effects on data collection reached far beyond health.

The company agreed earlier this month to offer the reduced pricing on TrumpRx.

Tying U.S. prices to what's paid abroad doesn't guarantee Americans will pay less — especially in Medicaid.

Seniors and providers have come to rely on Medicare paying for virtual visits since the COVID-19 pandemic.

The change could make women more willing to take hormone treatments for menopause.

Open enrollment started this week and shoppers are seeing higher rates.

The pilot program could make it easier for seniors to use drugs like Wegovy and Zepbound.

The new system is a win for drugmakers, but it could be a big hassle for providers.

A deal could significantly expand seniors' access to the popular drugs.

Commercial and academic tools are becoming more important as federal data becomes less available.

Many are concerned they could get squeezed out in the competition for a $50 billion rural health fund.

The Trump administration argues these procedures and tasks are being done more efficiently than the old payment rate reflects.

States started notifying residents they could be on the hook for thousands more dollars in out-of-pocket costs.